Embed Size (px)
Citation preview
FOR PROFESSIONAL INVESTORS ONLY www.generali-investments.com
Research Analysis
Last Contagion Figures
• September 24: 314,127 total new cases (+1.0%), vs 311,127 the previous day and 293,151 7-day average. Now confirmed 32,193,910 cases worldwide (213 countries and territories) vs 30,141,854 cases last week.
• 982,416 people have died (3.1% of confirmed cases) and 23,699,230 have recovered (73.6%).
• Europe: 4,149,470 cases; 7-day average growth of 56,871. USA: 6,977,658 cases; 7-day average growth of 43,321.
• Brazil: 4,659,909 cases, 7-day average growth of 28,924. India: 5,816,103 cases, 7-day average growth of 86,202.
• On Sept. 24 France recorded a new record for daily cases, with more than 16,000 new contagions. In the past 7 days more than 2 million people have been diagnosed with Covid-19, the highest number since the beginning of the pan-demic.
COVID-19 UPDATE
Facts & Figures – 25/09/2020
Issued September 25, 2020
2 | Generali Investments – Covid-19 Update
FOR PROFESSIONAL INVESTORS ONLY www.generali-investments.com
Research Analysis
3 | Generali Investments – Covid-19 Update
FOR PROFESSIONAL INVESTORS ONLY www.generali-investments.com
Research Analysis
Total 1-Day 7D avg Total 1-Day 7D avg
USA 6,977,658 + 44,110 + 43,321 202,798 + 914 + 738
India 5,816,103 + 85,919 + 86,202 92,317 + 1,144 + 1,130
Brazil 4,659,909 + 32,129 + 28,924 139,883 + 818 + 693
Russia 1,128,836 + 6,595 + 6,222 19,948 + 149 + 127
Colombia 790,823 + 6,555 + 6,697 24,924 + 178 + 180
Peru 788,930 + 6,235 + 5,547 31,938 + 68 + 113
Mexico 710,049 + 4,786 + 4,160 74,949 + 601 + 424
Spain 704,209 + 10,653 + 11,223 31,118 + 84 + 102
Argentina 678,266 + 13,467 + 10,936 14,766 + 390 + 329
South Africa 667,049 + 1,861 + 1,640 16,283 + 77 + 73
TOP 10 most hit countries
Cases DeathsCountry
Total 1-Day 7D avg Total 1-Day 7D avg
Asia ex China 10,363,592 + 119,267 + 118,138 188,818 + 1,817 + 1,814
North America 8,360,688 + 54,337 + 53,024 299,264 + 1,584 + 1,260
South America 7,758,638 + 63,803 + 57,079 244,533 + 1,684 + 1,459
Europe 4,149,470 + 68,436 + 56,871 209,494 + 576 + 526
Africa 1,444,619 + 8,186 + 7,944 34,758 + 171 + 182
Oceania 30,868 + 91 + 82 900 + 5 + 5
Others 721 - - 15 - -
* Regional class i fication according to the United Nations Geoscheme; Russ ia included in As ia
CountryCases Deaths
Most hit regions
4 | Generali Investments – Covid-19 Update
FOR PROFESSIONAL INVESTORS ONLY www.generali-investments.com
Research Analysis
Note: Data sources: WHO, CDC, ECDC, JHU, Worldometers.info, state and national government health departments, local media reports, Google Mobility Report, OpenTable, Bloomberg. The day is reset after midnight GMT+0. For addi-tional information regarding the data collected and presented in this document please contact [email protected]
Main news
• G7 finance ministers are expected to signal their support for extending a debt relief programme aimed at helping the poorest countries.
• SinoVac’s CEO said the company will be ready for worldwide distribution of its coronavirus vaccine by early next year.
• Moderna says it expect to produce 20 million doses of its experimental vaccine by the end of the year.
• Johnson & Johnson announced it will start Phase 3 trials for its coronavirus vaccine enrolling 60,000 volunteers.
• Rio’s Carnival had been delayed to for the first time in over a century.
• France and the UK implemented new restrictions, including closing bars and restaurants early and limiting public gath-erings to 10 people. Spain is also expected to announce new restrictions on Friday.
• The US and Canada have extended existing border restrictions until October 21. Similar restrictions apply also to the USA-Mexico border.
• Canada agreed to purchase up to 72 million vaccine doses from Sanofi and GSK.
• The European Commission finalized a deal with Sanofi and GSK to purchase up to 300 million doses of their vaccine.
Stage Phase N°
3 9
2 3
1/2 10
1 16
38
149 Preclinical Evaluation
*Data from the World Health Organization landscape documents
COVID-19 candidate vaccines
Total Clinical Evaluation
Clinical Evaluation
+2
+2
+3
5 | Generali Investments – Covid-19 Update
Imprint
Working with you since 1831
This document is based on information and opinions which Generali Insurance Asset Management S.p.A. Società di gestione del risparmio considers as reliable. However, no representation or warranty, expressed or implied, is made that such information or opinions are accurate or complete. Generali Insurance Asset Management S.p.A. Società di gestione del risparmio periodically updating the contents of this document, relieves itself from any responsibility concerning mistakes or omissions and shall not be considered responsible in case of possible changes or losses related to the improper use of the information herein provided. Opinions expressed in this document represent only the judgment of Generali Insurance Asset Management S.p.A. Società di gestione del risparmio and may be subject to any change without notification. They do not constitute an evaluation of any strategy or any investment in financial instruments. This document does not constitute an offer, solicitation or recommendation to buy or to sell financial instruments. Generali Insurance Asset Management S.p.A. Società di gestione del risparmio is not liable for any investment decision based on this document. Generali Investments may have taken, and may in the future take, investment decisions for the portfolios it manages which are contrary to the views expressed herein. Any reproduction, total or partial, of this document is prohibited without prior consent of Generali Insurance Asset Management S.p.A. Società di gestione del risparmio. Generali Investments is part of the Generali Group which was established in 1831 in Trieste as Assicurazioni Generali Austro-Italiche. Generali Investments is a commercial brand of Generali Investments Partners S.p.A. Società di gestione del risparmio, Generali Insurance Asset Manage-ment S.p.A. Società di gestione del risparmio, Generali Investments Luxembourg S.A. and Generali Investments Holding S.p.A..
www.generali-investments.com
In Italy: Generali Insurance Asset Management S.p.A Società di gestione del risparmio Piazza Tre Torri 20145 Milano MI, Italy Via Niccolò Machiavelli, 4 34132 Trieste TS, Italy
In France: Generali Insurance Asset Management S.p.A Società di gestione del risparmio 2, Rue Pillet-Will 75009 Paris Cedex 09, France
In Germany: Generali Insurance Asset Management S.p.A. Società di gestione del risparmio Tunisstraße 19-23 50667 Cologne, Germany
Head of Research Vincent Chaigneau ([email protected])
Head of Macro & Market Research: Dr. Thomas Hempell, CFA ([email protected])
Team: Elisabeth Assmuth ([email protected])
Elisa Belgacem ([email protected])
Radomír Jáč ([email protected])
Jakub Krátký ([email protected])
Michele Morganti ([email protected])
Vladimir Oleinikov, CFA ([email protected])
Dr. Martin Pohl ([email protected])
Dr. Thorsten Runde ([email protected])
Dr. Christoph Siepmann ([email protected])
Dr. Florian Späte, CIIA ([email protected])
Dr. Martin Wolburg, CIIA ([email protected])
Paolo Zanghieri, PhD ([email protected])
Head of Insurance and AM Research: Michele Morganti ([email protected])
Team: Raffaella Bagata ([email protected])
Alberto Cybo-Ottone, PhD ([email protected])
Mattia Mammarella ([email protected])
Roberto Menegato ([email protected])
Giovanni Millo, PhD ([email protected])
Antonio Salera, PhD ([email protected])
Cristiana Settimo ([email protected])
Federica Tartara, CFA ([email protected])
Issued by: Generali Insurance Asset Management S.p.A., Research Department
Sources for charts and tables: Thomson Reuters Datastream, Bloomberg, own calculations
